Sign up USA
Proactive Investors - Run By Investors For Investors
52-week High/Low: $39.35 / $14.52
Sector: Pharmaceuticals
Market Cap: $2,105.81M
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals (NASDAQ: ACAD) is a biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. We have a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson's disease psychosis.

ACADIA Pharmaceuticals Inc.

Interactive graph

col 3
col 4
col 5
col 6

ACADIA Pharmaceuticals Inc. Timeline

Market Reports Including ACAD

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use